Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9065
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSimadibrata, Marcellus-
dc.contributor.authorNursyirwan, Saskia Aziza-
dc.contributor.authorPribadi, Rabbinu Rangga-
dc.contributor.authorAbigael, Angelica-
dc.contributor.authorTanjaya, Lidya-
dc.date.accessioned2024-12-14T06:53:43Z-
dc.date.available2024-12-14T06:53:43Z-
dc.date.issued2024-07-
dc.identifier.citationCase Reporten_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9065-
dc.description.abstractGastrointestinal toxicities of radiation might develop after exposure, thus leading to conditions such as abdominal pain, rectal bleeding, diarrhea, anemia, and weight loss. The development of drugs to reduce mucosal damage progression has been a focus on managing radiation proctitis. Radiation proctitis resulting from exposure to pelvic radiotherapies is effectively managed with topical administration on the anal mucosa. The clinical use of hyaluronic acid offers an innovative approach to managing radiation injury. Hyaluronic acid has multiple beneficial properties, such as regulating immune process to reduce inflammation and oxidative stress, supporting natural protective mechanism, promoting mucosa healing, and improving tissue hydration. Therefore, this case series introduces the idea that application of hyaluronic acid could potentially improve patients’ clinical conditions.en_US
dc.language.isoen_USen_US
dc.publisherActa Medica Indosianaen_US
dc.subjectradiation proctitisen_US
dc.subjecthyaluronic aciden_US
dc.subjectenemaen_US
dc.titleEfficacy of Hyaluronic Acid in Radiation Proctitis: A Case Seriesen_US
dc.typeArticleen_US
Appears in Collections:VOL 56 NO 3 2024

Files in This Item:
File Description SizeFormat 
378-382.pdf1.53 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.